There was no significant correlation between COX-2 expression and any clinicopathologic characteristics, including gender, age, lymph node metastasis, histological differentiation, invasion depth and TNM stage (P > 0.05, chi-square test). The gene discussed is PTGS2; the disease is metastatic malignant neoplasm in the lymph nodes.